Skip to main content
Advanced Technologies for Industry logo

Research Center Pharmaceutical Engineering GmbH

Type
Research Center
Address

Inffeldgasse 13
8010 Graz
Austria

Description

Research Center Pharmaceutical Engineering GmbH

Founded in 2008, RCPE GmbH is an independent research center located in Graz (Austria) that performs cutting-edge research in the field of pharmaceutical process and product design.

Every day, we help our partners to develop and pioneer novel drugs and associated production routes, providing safe and more affordable therapies to patients. From early development to commercial production, we accompany our partners through all phases, utilizing our science-based, mechanistic understanding of products and processes.

As an international driver of pharmaceutical engineering science, RCPE offers tailored solutions to our partners, building upon our advanced capabilities in modeling and simulation, material science, PAT and process design. Moreover, RCPE features an international, multidisciplinary research team, unique laboratories and pilot plants suitable for even potent APIs.

 

RCPE is part of the following networks, clusters and initiatives:
human.technology.styria
BioNanoNet
Pharmig
International Institute for Advanced Pharmaceutical Manufacturing
European Consortium for Continuous Pharmaceutical Manufacturing

SPIRE

 

Research Center Pharmaceutical Engineering GmbH

Research Center Pharmaceutical Engineering GmbH

Contact Person
Thomas Kurt KLEIN
CEO
E-mail
thomas.klein@rcpe.at
is SME contact
Noreen Grünauer
Director Public Funding
E-mail
noreen.gruenauer@rcpe.at
Phone
+43 676 9121710
is SME contact
Equipment

RCPE Pilot Plant (ISO 9001, ISO 14001)

The pilot plant is extensively equipped, including a continuous extrusion system with hot-melt extruders, a wet extruder, a die-face cutter, a pelletizer, various feeding systems, a fully-instrumented laboratory tablet press, fluid-bed systems, a compaction simulator, granulators, nano-spray driers, capsule filling systems, filters, blenders, drug printers, crystallizers, coaters and much more.
The machines are used for process development, process understanding and the implementation of process-analytical tools for in-process monitoring, control and process optimization.

Regular maintenance and certification of the equipment and extensive training of the employees guarantee top research results and performance.

  • State-of-the-art pilot plant
  • Mixers, wet & dry granulators, compaction, coating, spray drying, continuous processing, etc.
  • Online NIR, Raman, UVVis, OCT, NIR GMP certified
  • 500 m2 of state-of-the-art facilities
  • Pharma Standard Clean Rooms (ISO 7) up to OEB 4 level

 

RCPE Laboratory Facilities (ISO 9001, ISO 14001)

Over the last years, RCPE has developed its own process and analytical laboratory with state-of-the-art equipment.

At the laboratory facility solid dosage forms are investigated (powders, tablets, pills, pellets, granules, capsules, etc.) which are relevant to pharmaceutical applications. For material characterization, comprehensive laboratory equipment is available. The analytics laboratory (chemical identification via UPLC, HPLC, 2 online NIRs, FTIR, online-Raman, UV-Vis, dissolution, particle analysis, structure, flowability, DSC, X-ray, etc.) comprises state-of-the-art equipment as well.

  • State-of-the-art analytical laboratory
  • Detailed maintenance plans
  • Equipment certification available

 

Services

RCPE provides independent R&D in the field of pharmaceutical engineering, bridging the gap between science and industrial applications, ensuring pharmaceutical companies have the necessary predictive tools, methods and approaches to benefit from regulatory and industry-driven initiatives such as Quality by Design.

It is our intention to make our research capabilities and technological background available for companies on a service basis. Typical examples include measurements using our vast experimental and analytical capabilities, literature studies, feasibility studies, design studies, simulation work and other types of services.

Benefits

  • Diverse Research Activities
    small preparatory studies up to extensive multi-year research programs are possible
  • Proven Scientific Excellence
    multi-disciplinary teams, dedicated to customer needs
  • Maximum Output for Partners
    defined & clear IPR strategies
  • Flexible Business Models
    funded & non-funded cooperation scenarios to maximize cost efficiency
  • Established Industrial/Scientific Network
    single-source repository for pharmaceutical engineering
Service for Industry and SMEs
Yes